BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 9617509)

  • 1. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial.
    Segal J; Berk M; Brook S
    Clin Neuropharmacol; 1998; 21(3):176-80. PubMed ID: 9617509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol.
    Smulevich AB; Khanna S; Eerdekens M; Karcher K; Kramer M; Grossman F
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):75-84. PubMed ID: 15572276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study.
    Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V
    Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and continuation risperidone monotherapy in mania.
    Vieta E; Brugué E; Goikolea JM; Sánchez-Moreno J; Reinares M; Comes M; Colom F; Martínez-Arán A; Benabarre A; Torrent C
    Hum Psychopharmacol; 2004 Jan; 19(1):41-5. PubMed ID: 14716711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
    Lenox RH; Newhouse PA; Creelman WL; Whitaker TM
    J Clin Psychiatry; 1992 Feb; 53(2):47-52. PubMed ID: 1541605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial.
    Akhondzadeh S; Mohajari H; Reza Mohammadi M; Amini H
    BMC Psychiatry; 2003 Jun; 3():7. PubMed ID: 12816549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone in the treatment of mania.
    Tohen M; Zarate CA; Centorrino F; Hegarty JI; Froeschl M; Zarate SB
    J Clin Psychiatry; 1996 Jun; 57(6):249-53. PubMed ID: 8666562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
    McElroy SL; Keck PE; Stanton SP; Tugrul KC; Bennett JA; Strakowski SM
    J Clin Psychiatry; 1996 Apr; 57(4):142-6. PubMed ID: 8601548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania.
    Chan HY; Jou SH; Juang YY; Chang CJ; Chen JJ; Chen CH; Chiu NY
    Psychiatry Clin Neurosci; 2010 Apr; 64(2):162-9. PubMed ID: 20447012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone monotherapy in manic inpatients: an open label, multicentre trial.
    Forsthoff A; Grunze H; Seemüller F; Stampfer R; Dittmann S; Amann B; Schmidt F; Schäfer M; Hermle L; Walden J; Schreiner A
    World J Biol Psychiatry; 2007; 8(4):256-61. PubMed ID: 17853251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.